Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kastrissios

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Annual Review of Pharmacology and Toxicology|January 1, 1997
Medication compliance as a feature in drug developmentH Kastrissios, T F Blaschke
Cancer Investigation|April 9, 2001
Screening for sources of interindividual pharmacokinetic variability in anticancer drug therapy: utility of population analysisH Kastrissios, M J Ratain
The Journal of Pharmacy and Pharmacology|March 29, 2001
Pharmacokinetics of diaspirin cross-linked haemoglobin in a rat model of hepatic cirrhosisR Palaparthy, H Kastrissios, A Gulati
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetics of high-dose oral CCNU in bone marrow transplant patientsH Kastrissios, N J Chao, T F Blaschke
Clinical Chemistry|March 1, 1996
Improved combined solid-phase extraction-RIA method for quantifying zalcitabine in plasmaH Kastrissios, M Nakano, P Burton, et al.
Clinical Pharmacology and Therapeutics|May 1, 1996
Introducing medical students to medication noncomplianceH Kastrissios, N T Flowers, T F Blaschke
Journal of Chromatography|May 20, 1992
High-performance liquid chromatographic method for the quantitation of bupivacaine, 2,6-pipecoloxylidide and 4'-hydroxybupivacaine in plasma and urineH Kastrissios, M F Hung, E J Triggs
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1996
Do we need full compliance data for population pharmacokinetic analysis?P Girard, L B Sheiner, H Kastrissios, et al.
Statistics in Medicine|November 20, 1998
A Markov mixed effect regression model for drug complianceP Girard, T F Blaschke, H Kastrissios, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Plasma concentrations of bupivacaine after wound infiltration of an 0.5% solution after inguinal herniorrhaphy: a preliminary studyH Kastrissios, E J Triggs, F Sinclair, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Annual Review of Pharmacology and Toxicology|January 1, 1997
Medication compliance as a feature in drug developmentH Kastrissios, T F Blaschke
Cancer Investigation|April 9, 2001
Screening for sources of interindividual pharmacokinetic variability in anticancer drug therapy: utility of population analysisH Kastrissios, M J Ratain
The Journal of Pharmacy and Pharmacology|March 29, 2001
Pharmacokinetics of diaspirin cross-linked haemoglobin in a rat model of hepatic cirrhosisR Palaparthy, H Kastrissios, A Gulati
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetics of high-dose oral CCNU in bone marrow transplant patientsH Kastrissios, N J Chao, T F Blaschke
Clinical Chemistry|March 1, 1996
Improved combined solid-phase extraction-RIA method for quantifying zalcitabine in plasmaH Kastrissios, M Nakano, P Burton, et al.
Clinical Pharmacology and Therapeutics|May 1, 1996
Introducing medical students to medication noncomplianceH Kastrissios, N T Flowers, T F Blaschke
Journal of Chromatography|May 20, 1992
High-performance liquid chromatographic method for the quantitation of bupivacaine, 2,6-pipecoloxylidide and 4'-hydroxybupivacaine in plasma and urineH Kastrissios, M F Hung, E J Triggs
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1996
Do we need full compliance data for population pharmacokinetic analysis?P Girard, L B Sheiner, H Kastrissios, et al.
Statistics in Medicine|November 20, 1998
A Markov mixed effect regression model for drug complianceP Girard, T F Blaschke, H Kastrissios, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Plasma concentrations of bupivacaine after wound infiltration of an 0.5% solution after inguinal herniorrhaphy: a preliminary studyH Kastrissios, E J Triggs, F Sinclair, et al.
Pageof 3